Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2011

01-12-2011 | Poster presentation

Lobular carcinoma of the breast: outcome of 205 patients

Authors: E Vega, E Ciruelos, N Valdiviezo, C Mendiola, L Manso, I Ghanem, M Dorta, T Pascual, C Flores, H Cortés-Funes

Published in: Breast Cancer Research | Special Issue 2/2011

Login to get access

Excerpt

Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer (BC), which comprises approximately 10% of BC and appears to have distinct biologic and epidemiologic characteristics. …
Metadata
Title
Lobular carcinoma of the breast: outcome of 205 patients
Authors
E Vega
E Ciruelos
N Valdiviezo
C Mendiola
L Manso
I Ghanem
M Dorta
T Pascual
C Flores
H Cortés-Funes
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2011
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3028

Other articles of this Special Issue 2/2011

Breast Cancer Research 2/2011 Go to the issue

Oral presentation

DNA repair and breast cancer: therapeutic opportunities

Oral presentation

Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma

Oral presentation

Molecular classification of triple-negative tumors

Poster presentation

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples

Poster presentation

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy

Poster presentation

Clinical features and prognosis of tubular breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits